Universal Ibogaine Stock Market Value

IBOGF Stock  USD 0.01  0.0009  17.65%   
Universal Ibogaine's market value is the price at which a share of Universal Ibogaine trades on a public exchange. It measures the collective expectations of Universal Ibogaine investors about its performance. Universal Ibogaine is trading at 0.006 as of the 25th of December 2025. This is a 17.65 percent increase since the beginning of the trading day. The stock's lowest day price was 0.006.
With this module, you can estimate the performance of a buy and hold strategy of Universal Ibogaine and determine expected loss or profit from investing in Universal Ibogaine over a given investment horizon. Check out Universal Ibogaine Correlation, Universal Ibogaine Volatility and Universal Ibogaine Alpha and Beta module to complement your research on Universal Ibogaine.
Symbol

Please note, there is a significant difference between Universal Ibogaine's value and its price as these two are different measures arrived at by different means. Investors typically determine if Universal Ibogaine is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Universal Ibogaine's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Universal Ibogaine 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Universal Ibogaine's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Universal Ibogaine.
0.00
06/28/2025
No Change 0.00  0.0 
In 5 months and 30 days
12/25/2025
0.00
If you would invest  0.00  in Universal Ibogaine on June 28, 2025 and sell it all today you would earn a total of 0.00 from holding Universal Ibogaine or generate 0.0% return on investment in Universal Ibogaine over 180 days. Universal Ibogaine is related to or competes with Innate Pharma, Brii Biosciences, Scancell Holdings, JW (Cayman), NervGen Pharma, Ascend Wellness, and Santhera Pharmaceuticals. Universal Ibogaine Inc., a life sciences company, develops, acquires, and operates addiction treatment clinics in Canada More

Universal Ibogaine Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Universal Ibogaine's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Universal Ibogaine upside and downside potential and time the market with a certain degree of confidence.

Universal Ibogaine Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Universal Ibogaine's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Universal Ibogaine's standard deviation. In reality, there are many statistical measures that can use Universal Ibogaine historical prices to predict the future Universal Ibogaine's volatility.
Hype
Prediction
LowEstimatedHigh
0.000.0118.99
Details
Intrinsic
Valuation
LowRealHigh
0.000.0118.99
Details
Naive
Forecast
LowNextHigh
0.00010.0118.98
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
00.010.01
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Universal Ibogaine. Your research has to be compared to or analyzed against Universal Ibogaine's peers to derive any actionable benefits. When done correctly, Universal Ibogaine's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Universal Ibogaine.

Universal Ibogaine Backtested Returns

Universal Ibogaine appears to be out of control, given 3 months investment horizon. Universal Ibogaine owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0415, which indicates the firm had a 0.0415 % return per unit of risk over the last 3 months. By inspecting Universal Ibogaine's technical indicators, you can evaluate if the expected return of 0.79% is justified by implied risk. Please review Universal Ibogaine's Semi Deviation of 16.21, risk adjusted performance of 0.03, and Coefficient Of Variation of 3453.02 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Universal Ibogaine holds a performance score of 3. The entity has a beta of -0.19, which indicates not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Universal Ibogaine are expected to decrease at a much lower rate. During the bear market, Universal Ibogaine is likely to outperform the market. Please check Universal Ibogaine's potential upside, daily balance of power, and the relationship between the treynor ratio and expected short fall , to make a quick decision on whether Universal Ibogaine's existing price patterns will revert.

Auto-correlation

    
  0.45  

Average predictability

Universal Ibogaine has average predictability. Overlapping area represents the amount of predictability between Universal Ibogaine time series from 28th of June 2025 to 26th of September 2025 and 26th of September 2025 to 25th of December 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Universal Ibogaine price movement. The serial correlation of 0.45 indicates that just about 45.0% of current Universal Ibogaine price fluctuation can be explain by its past prices.
Correlation Coefficient0.45
Spearman Rank Test0.55
Residual Average0.0
Price Variance0.0

Universal Ibogaine lagged returns against current returns

Autocorrelation, which is Universal Ibogaine pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Universal Ibogaine's pink sheet expected returns. We can calculate the autocorrelation of Universal Ibogaine returns to help us make a trade decision. For example, suppose you find that Universal Ibogaine has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Universal Ibogaine regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Universal Ibogaine pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Universal Ibogaine pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Universal Ibogaine pink sheet over time.
   Current vs Lagged Prices   
       Timeline  

Universal Ibogaine Lagged Returns

When evaluating Universal Ibogaine's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Universal Ibogaine pink sheet have on its future price. Universal Ibogaine autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Universal Ibogaine autocorrelation shows the relationship between Universal Ibogaine pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Universal Ibogaine.
   Regressed Prices   
       Timeline  

Currently Active Assets on Macroaxis

Other Information on Investing in Universal Pink Sheet

Universal Ibogaine financial ratios help investors to determine whether Universal Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Universal with respect to the benefits of owning Universal Ibogaine security.